Last updated on Sun, 04/30/2017 - 01:52
Highest mark: ?
Other SAQs in this paper
List the problems associated with massive transfusion in the critically ill. Outline your principles of management for each.
Massive transfusion (eg. replacement of more than 50% of blood volume in 12 to 24 hours, or one circulation blood volume in 24 hrs [T Oh]) is associated with many potential problems which are related to a number of factors including the volume of resuscitation, factors related to the storage blood, and many other related issues. Problems include:
• Volume overload (careful monitoring of filling pressure, response to volume, diuresis)
• Over-transfusion (monitor Hb regularly, titrate according to needs)
• Hypothermia (use of fluid warmers and general measures to minimise heat loss)
• Dilutional coagulopathy of both clotting factors and platelets (regular and early monitoring of coagulation, and involvement of haematology for replacement therapy [better than according to protocol])
• Transfusion related lung injury (consider use of filters, leukodepletion)
• Excessive citrate causing metabolic alkalosis and hypocalcemia (monitor pH and ionised calcium, replace calcium as necessary)
• Hyperkalaemia (use of “younger” blood, monitor regularly, may require specific therapy)
• Disease transmission (use of products on as needed basis only, standard blood banking precautions)
• Distractions resulting in not controlling source of haemorrhage, and risks of hurried cross-checking and incompatibility (allocation of sufficient resources and personnel, standard programs in place to facilitate process and anticipate needs)
• Other problems include loss of identity (cross matching issues, loss of baseline haematological information etc.)
Massive transfusion is discussed in greater detail elsewhere. Several definitions exist, but the replacement of 1 blood volume is a popular one.
In fact, and excellent article from Chest (2010) has a nice table (Table 1) of complications from massive transfusion. That table was a strong (dominating) influence on the following list of complications:
- Acute hemolytic transfusion reactions
- Febrile nonhemolytic transfusion reactions
- Tranfusion-associated lung injury (TRALI)
- Transfusion-associated circulatory overload (TACO)
- Allergic reactions to blood products
- Bacterial sepsis due to contaminated blood products
- Hypocalcemia due to citrate
- Hyperkalemia due to high PRBC K+ content
- Acidosis due to high PRBC lactate content
- Hypothermia due to use of recently refrigerated PRBCs
- Dilutional coagulopathy due to inappropriate blood product replacement proportions
- Dilutional thrombocytopenia due to lack of platelet replacement
- Delayed hemolytic transfusion reactions
- Transfusion-related immune modulation (TRIM)
- Microchimerism - the persistence of an allogeneic cell population of leucocytes
- Transfusion-transmitted diseases, eg. HIV, Hep C
- Posttransfusion graft-vs-host disease (due to non-leukodepleted PRBCs)
- Posttransfusion purpura
The college allso asks the candidate to "outline your management for each".
This requires a large table. The Australian Red Cross Blood Service have a nice table for management steps of transfusion reactions.
|Acute hemolytic transfusion reactions||
|Febrile nonhemolytic transfusion reactions||
|Allergic reaction to blood products||
|Tranfusion-associated lung injury||
|Transfusion-associated circulatory overload||
|Hypocalcemia due to citrate||
|Hyperkalemia due to high PRBC K+ content||
|Delayed hemolytic transfusion reactions||
|Transfusion-related immune modulation||
|Posttransfusion graft-vs-host disease||
Sihler, Kristen C., and Lena M. Napolitano. "Complications of massive transfusion." CHEST Journal 137.1 (2010): 209-220.
Capon, Stephen M., and Dennis Goldfinger. "Acute hemolytic transfusion reaction, a paradigm of the systemic inflammatory response: new insights into pathophysiology and treatment." Transfusion 35.6 (1995): 513-520.
Perrotta, P. L., and E. L. Snyder. "Non-infectious complications of transfusion therapy." Blood reviews 15.2 (2001): 69-83.
Beauregard, Patrice, and Morris A. Blajchman. "Hemolytic and pseudo-hemolytic transfusion reactions: an overview of the hemolytic transfusion reactions and the clinical conditions that mimic them." Transfusion medicine reviews 8.3 (1994): 184-199.
Reed, William, et al. "Transfusion-associated microchimerism: a new complication of blood transfusions in severely injured patients." Seminars in hematology. Vol. 44. No. 1. WB Saunders, 2007.
Anderson, Kenneth C., and Howard J. Weinstein. "Transfusion-associated graft-versus-host disease." New England Journal of Medicine 323.5 (1990): 315-321.
Yokoyama, Ana Paula Hitomi, et al. "Diagnosis and Management Of POST-Transfusion Purpura-Case Report." Blood 122.21 (2013): 4834-4834.